Catastrophic antiphospholipid syndrome after severe maxillofacial trauma treated effectively with combined therapy in the intensive care unit. An "imaging" case

Journal of Trauma - Injury, Infection and Critical Care

Volumn 66, Issue 6, 2009, Pages 1724-1727

  Karakitsos, Dimitrios ^a   Saranteas, Theodosios ^a   Poularas, John ^a   Paramythiotou, Elisabeth ^a   Gravanis, Andreas ^a   Karabinis, Andreas ^a   Mourouzis, Konstantinos ^b   Brennan, Peter A ^b  

^a IASO GENERAL HOSPITAL   (Greece)

^b QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; HEPARIN; HYPERTENSIVE AGENT; METHYLPREDNISOLONE; PREDNISONE; WARFARIN;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; ELECTROCARDIOGRAM; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; HUMAN TISSUE; INTENSIVE CARE UNIT; KIDNEY BIOPSY; LABORATORY TEST; MALE; MAXILLOFACIAL INJURY; PLASMAPHERESIS; PRIORITY JOURNAL; TERMINAL DISEASE; ULTRASOUND; ACUTE KIDNEY FAILURE; BRAIN INJURY; MULTIPLE ORGAN FAILURE; TRAFFIC ACCIDENT;

ACCIDENTS, TRAFFIC; ADULT; ANTIPHOSPHOLIPID SYNDROME; BRAIN INJURIES; HUMANS; INTENSIVE CARE UNITS; KIDNEY FAILURE, ACUTE; MALE; MAXILLOFACIAL INJURIES; MULTIPLE ORGAN FAILURE;

EID: 67749114321     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/01.ta.0000243386.77986.dd     Document Type: Article

References (19)

1. Asherson RA, Cervera R, Piette J-C, et al. Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine. 2001;80:355-377. (Pubitemid 33070843)
2. Petri M. Evidence-based management of thrombosis in the antiphospholipid antibody syndrome. Curr Rheumatol Rep. 2003; (5):370-373.
3. Westney G, Harris EN. Catastrophic antiphospholipid syndrome in the intensive care unit. Crit Care Med. 2002;18:805-817. (Pubitemid 35215562)
4. Rosner E, Pauzner R, Lusky A, Modan M, Many A. Detection and quantitative evaluation of lupus circulating anticoagulant activity. Thromb Haemost. 1987;57:144-147. (Pubitemid 18024502)
5. Barak N, Orion Y, Cordoba M, Mekori YA. Catastrophic antiphospholipid syndrome triggered by trauma. J Rheumatol. 1999; 26:1835-1836. (Pubitemid 29367329)
6. Brandt JT, Triplett DA, Alving B, et al. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcomittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost. 1995;74:1185-1190.
7. Asherson R. The catastrophic antiphospholipid syndrome. J Rheumatol. 1992;19:508-512.
8. Asherson RA, Cervera R, de Groot PG. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus. 2003;12:530-534. (Pubitemid 36890145)
9. Asherson RA, Cavera R. Antiphospholipid syndrome. In: Kelly WR, Harris ED eds. Rheumatology. Philadelphia: WB Saunders; 1997:1057-1064.
10. Amigo MC, Garcia-Torres R. Morphology of vascular, renal, and heart lesions in the antiphospholipid syndrome: relationship to pathogenesis. Curr Rheumatol Rep. 2000;2:262-270.
11. Cisternas M, Gutierrez MA, Rosenberg H, Jara A, Jacobelli S. Catastrophic antiphospholipid syndrome associated with crescentic glomerulonephritis: a clinicopathologic case. Clin Exp Rheumatol. 2000;18:252-254. (Pubitemid 30208273)
12. Erkan D, Cervera R, Asherson RA. Catastrophic antiphospholipid syndrome: where do we stand? Arthritis Rheum. 2003;48:3320-3327. (Pubitemid 37531898)
13. Galli M, Finazzi G, Duca F, Norbis F, Moia M. G1691-A mutation of factor V, but not the G20210-A mutation of factor II or the C677- T mutation of methylene tetrahydrofolate reductase genes, is associated with venous thrombosis in patients with lupus anticoagulants. Br J Haematol. 2002;108:865-870.
14. Topaloglu R, Akierli C, Bakkaloglu A, et al. Survey of factor V leiden and prothrombin gene mutations in systemic lupus erythematosus. Clin Rheumatol. 2001;20:259-613. (Pubitemid 32776469)
15. Higginbotham EA, Zimmerman SA, Howard TA, Schanberg L, Kredich D, Ware R. Effects of inherited thrombophilic mutations in an adolescent with antiphospholipid syndrome and systemic lupus erythematosus. J Rheumatol. 2001;28:370-372. (Pubitemid 32165151)
16. Asherson RA, Cervera R, Piette JC, et al. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore). 1998;77:195-207. (Pubitemid 28290020)
17. Rosove MH, Brewer PM. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med. 1992;117:303-308.
18. Krnic-Barrie S, O'Connor CR, Looney SW, Pierangeli SS, Harris EN. A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis. Arch Intern Med. 1997;157:2101-2108 (Pubitemid 27431279)
19. Erkan D, Asherson RA, Espinosa G, et al. Long term outcome of catastrophic antiphospholipid syndrome survivors. Ann Rheum Dis. 2003;62:530-533 (Pubitemid 36606285)